Article
Nature 438, 820-827 (8 December 2005) | doi:10.1038/nature04186; Received 13 May 2005; Accepted 19 August 2005
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Rosandra N. Kaplan1,2,6,10, Rebecca D. Riba1,2,10, Stergios Zacharoulis1,2,6,10, Anna H. Bramley1,2, Loïc Vincent4, Carla Costa1,2, Daniel D. MacDonald1,2, David K. Jin4, Koji Shido4, Scott A. Kerns1,2, Zhenping Zhu8, Daniel Hicklin8, Yan Wu8, Jeffrey L. Port5, Nasser Altorki5, Elisa R. Port7, Davide Ruggero9, Sergey V. Shmelkov1,2,4, Kristian K. Jensen1,2, Shahin Rafii3,4 & David Lyden1,2,6
- Department of Pediatrics and the Children's Blood Foundation Laboratories,
- Cell and Developmental Biology,
- Howard Hughes Medical Institute,
- Genetic Medicine and
- Surgery, Weill Cornell Medical College of Cornell University, 1300 York Avenue and
- Department of Pediatrics and
- Surgery, Memorial Sloan-Kettering Cancer Center, 1233 York Avenue, New York, New York 10021, USA
- Imclone Systems Incorporated, New York, New York 10014, USA
- Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
- *These authors contributed equally to this work
Correspondence to: Shahin Rafii3,4David Lyden1,2,6 Correspondence and requests for materials should be addressed to D.L. (Email: dcl2001@med.cornell.edu) or S.R. (Email: srafii@med.cornell.edu).
Abstract
The cellular and molecular mechanisms by which a tumour cell undergoes metastasis to a predetermined location are largely unknown. Here we demonstrate that bone marrow-derived haematopoietic progenitor cells that express vascular endothelial growth factor receptor 1 (VEGFR1; also known as Flt1) home to tumour-specific pre-metastatic sites and form cellular clusters before the arrival of tumour cells. Preventing VEGFR1 function using antibodies or by the removal of VEGFR1+ cells from the bone marrow of wild-type mice abrogates the formation of these pre-metastatic clusters and prevents tumour metastasis, whereas reconstitution with selected Id3 (inhibitor of differentiation 3)-competent VEGFR1+ cells establishes cluster formation and tumour metastasis in Id3 knockout mice. We also show that VEGFR1+ cells express VLA-4 (also known as integrin
4
1), and that tumour-specific growth factors upregulate fibronectin—a VLA-4 ligand—in resident fibroblasts, providing a permissive niche for incoming tumour cells. Conditioned media obtained from distinct tumour types with unique patterns of metastatic spread redirected fibronectin expression and cluster formation, thereby transforming the metastatic profile. These findings demonstrate a requirement for VEGFR1+ haematopoietic progenitors in the regulation of metastasis, and suggest that expression patterns of fibronectin and VEGFR1+VLA-4+ clusters dictate organ-specific tumour spread.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
S100 chemokines mediate bookmarking of premetastatic nichesNature Cell Biology News and Views (01 Dec 2006)
Cancer biology Emissaries set up new sitesNature News and Views (08 Dec 2005)
See all 4 matches for News And ViewsRESEARCH
Circulating vitamin E, transforming growth factor β1, and the association with renal disease susceptibility in two racial groups with type 2 diabetesKidney International Original Article
See all 16 matches for Research

